Sample size and power training for use in clinical trials

Webinar

Advantages & Disadvantages of
Adaptive Sample Size Re-Estimation

This webinar has taken place
and is now available on demand:

About the webinar

Join us to learn about the Advantages & Disadvantages of
Adaptive Sample Size Re-Estimation and how these can impact your trial.

Adaptive clinical trials seek to give control to trialist to improve the trial based on all available information. Given the high failure rates and the increased costs of clinical trials, researchers need such innovative design strategies to best optimize financial resources and reduce the risk to patients.

In this free webinar you will learn about

  • Advantages & Disadvantages of Adaptive Design
  • Evaluating Unblinded SSR for your trials
  • Evaluating Blinded SSR for your trials

Duration - 60 minutes

Speaker: Ronan Fitzpatrick, Head of Statistics, Statsols

Watch Now

All info submitted is secure. View our privacy policy.


About Our Host
Ronan Fitzpatrick

Ronan Fitzpatrick Circle Image 150px
Ronan Fitzpatrick is Head of Statistics at Statsols and the Lead Researcher for nQuery Sample Size Software. He has been a guest lecturer for many institutions including the FDA. 
Reducing the risk & cost of clinical trials, for innovative organizations such as:
Sanofi-updated-grey
worldwide-clinical-trials
Covance-G_Logo
quintiles_logo_2017_grey
FDA_G_Logo
AstellasG_Logo
celgene_logo_download
Boehringer_Ingelheim_Logo-png-updated
PRA_Health_Sciences
Astrazeneca logo
Amgen_G_Logo
Novartis_G_Logo
abbvie-logo-updated_tmp15240
Merck_GLogo
Biogen-updated-logo
Ipsen-logo-only
Eli_Lilly_and_Company-G_Logo
Is there someone in your network that would be interested in our webinar?
Share this page by clicking below.